Loading...

AbbVie Inc.

4AB.DUDUS
HealthcareMedical - Pharmaceuticals
166.20
2.20(1.34%)

AbbVie Inc. (4AB.DU) Company Profile & Overview

Explore AbbVie Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

AbbVie Inc. (4AB.DU) Company Profile & Overview

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

SectorHealthcare
IndustryMedical - Pharmaceuticals
CEORichard A. Gonzalez

Contact Information

Company Facts

50,000 Employees
IPO DateFeb 20, 2020
CountryUS
Actively Trading

Frequently Asked Questions